The Energy Code

Folgen

• 
  Ayurvedic Wisdom for Better Digestion, Performance & Bioenergetics | Dr. John Douillard 23.07.2026 1Std. 34Min.

  What happens when one of the world's leading experts in Ayurveda sits down with one of the leading voices in mitochondrial health? In this episode of The Energy Code, Dr. Mike Belkowski welcomes Dr. John Douillard for a wide-ranging conversation connecting ancient Ayurvedic medicine with modern physiology, mitochondria, circadian biology, digestion, lymphatic health, breathing, seasonal nutrition, and longevity. Dr. Douillard explains why digestion may be one of the true foundations of health, how the diaphragm powers the body's lymphatic system, why modern lifestyles disconnect us from natural biological rhythms, and why whole foods often outperform isolated compounds. Together they explore the science behind seasonal eating, breathing techniques, microbiome diversity, infrared light, melatonin, circadian medicine, and how aligning with nature may optimize energy production at the cellular level. Whether you're interested in mitochondria, performance, longevity, nutrition, or foundational health, this conversation bridges thousands of years of traditional wisdom with emerging scientific research. (Educational content only, not medical advice.) Articles & Books Discussed in Episode: Books by Dr. John Douillard: Eat Wheat, The 3-Season Diet, and Body, Mind, and Sport Research & References: Stanford Mummy Microbiome Diversity Study, International Journal of Neuroscience Nose-Breathing Study, Breath by James Nestor Key Quotes From Dr. John Douillard: “Rasa is the word for lymph. The study of the lymphatic system for Ayurveda was the study of longevity.” “If you can’t get the trash out of this body, you’re not going to be able to get the good stuff in.” “80% of your immune response is linked to these foods that create an immune response. If you bubblewrap your diet, you don't have a reason for gut immunity.” “When you add the plant and its natural microbiome, there’s nothing more potent than that, because it has the intelligence along with the biochemistry.” “The bigger the calm you have on the inside, the more powerful the winds you have on the outside.” “Melatonin is a 3-billion-year-old molecule. It isn’t a hormone... It tells your body when nighttime and winter are coming.” - Follow & Learn From Dr. John Douillard   Social Media:InstagramFacebookTikTokLinkedInXYouTube Website & Other:LifeSpa.com Newsletter Sign Uphttps://lifespa.com/appearances/  - Key Points ⚡ Dr. John Douillard shares his origin story from competitive triathlon training to studying ancient Ayurvedic medicine at a hospital in India. ⚡ In Ayurveda, Rasayana (longevity) is fundamentally tied to the study and health of the lymphatic system. ⚡ The lymphatic system handles waste removal, immune cell transportation, and baseline delivery of dietary fatty acid precursors for hormone production. ⚡ The diaphragm is the primary mechanical pump for both the body's lymphatics and the brain’s glymphatic waste-clearance system. ⚡ Studies reveal that 91% of elite athletes tested do not possess fully contracting and relaxing diaphragms due to chronic stress patterns. ⚡ Incompletely digested proteins and fats escape into the intestinal lymphatic collecting ducts, triggering systemic inflammation, brain fog, and skin eruptions. ⚡ "Bubble-wrapping" the diet by completely eliminating slightly irritating foods (like gluten, lectins, or nightshades) starves the gut of the hormetic irritation required for robust gut immunity. ⚡ Long-term continuous ketogenic diets bypass seasonal evolutionary biological cues, whereas seasonal fat-burning aligns with natural spring scarcity. ⚡ Dr. John demonstrates a step-by-step Maximum Inspiratory Breathing technique to break up rib cage scar tissue and reactivate full diaphragmatic movement. ⚡ Five key spices—ginger, cumin, coriander, fennel, and cardamom—naturally stimulate stomach acid, bile flow, pancreatic enzymes, and healthy gut microbes. ⚡ Cooking meat and foods with whole spices mitigates the free radic
• 
  Red Light Therapy for the Brain: Can it Protect Football Players From Head Injuries & Improve ADHD Impulse Control in Adults? 20.07.2026 28Min.

  In this Deep Dive, Dr. Mike Belkowski examines two new studies exploring transcranial photobiomodulation from completely different angles: protecting collegiate football players from the cumulative effects of repetitive head impacts and improving impulse control in adults with ADHD. The first study followed Division I football players across a full season and found that athletes using 810-nanometer transcranial and intranasal light maintained greater stability in MRI markers associated with neuroinflammation and axonal stress. The second study used 1,064-nanometer light over the right prefrontal cortex and reported improved impulse control, increased prefrontal oxygenation, and a 51% improvement in correct response inhibition among participants with ADHD after a single session. Although both studies are early and carry important limitations, they point toward the same underlying principle: brain health, resilience, and cognitive performance are deeply dependent on bioenergetics. Whether the goal is protecting the brain from repeated trauma or improving executive function, supporting mitochondrial energy production, oxygenation, and inflammatory balance may be the common lever. (Educational content only, not medical advice.) - Articles Discussed in Episode: Transcranial Photobiomodulation Promotes Neurological Resilience in Current Collegiate American Football Players Exposed to Repetitive Head Acceleration Events Transcranial photobiomodulation improves prefrontal oxygenation and impulse control in adults with ADHD: a randomized controlled trial - Key Quotes From Dr. Mike: “So much of brain health traces back to whether cells and mitochondria can make and utilize energy efficiently. “For every diagnosed concussion, hundreds of additional head-acceleration events may be occurring.” “Can we build resilience into the brain (via red light therapy) before the symptoms ever show up?” “The (near-infrared) light appeared to help precisely in the areas that needed it most.” “That improvement brought the ADHD group’s performance up to a level comparable with the non-ADHD participants.” “A brain with more energy and better oxygen delivery is both more resilient to insult and more capable of performing.” “Whether the goal is resilience or focus, the same lever keeps showing up: energy production, oxygenation, and inflammation control.” - Key Points ⚡ Two new studies examined transcranial photobiomodulation for two very different goals: neuroprotection in football players and cognitive enhancement in adults with ADHD. ⚡ The common mechanism connecting both studies is brain bioenergetics—how efficiently brain cells produce and use energy. ⚡ Red and near-infrared light interact with mitochondrial cytochrome c oxidase, supporting ATP production, oxygen utilization, blood flow, and cellular repair. ⚡ The football study evaluated whether near-infrared light could proactively build neurological resilience across a season of repetitive head impacts. ⚡ For every diagnosed concussion, football players may experience hundreds of additional subconcussive head-acceleration events. ⚡ These repetitive impacts may contribute to neuroinflammation, reduced white-matter integrity, altered brain activation, and cognitive decline. ⚡ The football study included 26 Division I athletes in a randomized, double-blind, sham-controlled design. ⚡ The active protocol used 810-nanometer light pulsed at 40 hertz for 20 minutes, three times weekly across a 16-week season. ⚡ The device targeted nodes of the default mode network and included an intranasal LED for deeper light delivery. ⚡ Diffusion MRI markers associated with neuroinflammation and axonal stress increased across the season in the sham group. ⚡ Players receiving active PBM showed greater stability in those markers and, in some brain regions, measurable reductions. ⚡ The areas showing the strongest protective effects closely matched the brain’s known “cone of vulnerability” to mechanical trauma. ⚡
• 
  The Mitochondrial Multivitamin: Why Vitamin M Changes Everything 16.07.2026 52Min.

  In this foundational episode of The Energy Code, Dr. Mike Belkowski challenges the conventional multivitamin and introduces Vitamin M, BioLight’s most advanced mitochondrial supplement to date. Traditional multivitamins were designed to prevent deficiency diseases — not to optimize energy, cognition, resilience, or longevity. Dr. Mike explains why many formulas rely on inexpensive nutrient forms, token doses, competing ingredients, and labels with no unifying biological purpose. Vitamin M takes the opposite approach, beginning with one central question: What does a mitochondrion actually need to produce energy and remain resilient? The episode walks through the formula ingredient by ingredient, organizing Vitamin M into four coordinated systems: replenishing NAD and cellular energy currency, supplying the cofactors required to produce ATP, reinforcing antioxidant defenses, and supporting methylation, DNA repair, and homocysteine management. Featuring NMN, niacinamide, ubiquinol, active B vitamins, alpha-lipoic acid, taurine, glycine, trace minerals, TMG, and folinic acid, Vitamin M is designed to support sustained cellular energy without caffeine or stimulants. This is not another kitchen-sink multivitamin — it is a coordinated mitochondrial system built from the ground up. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Americans spend somewhere north of eight billion dollars a year on multivitamins.” “Calling these multivitamins expensive urine might actually be too generous.” “You are only as young as your mitochondria.” "Mitochondrial health isn't another wellness trend — it's the foundation beneath every wellness trend." “What does a mitochondrion actually need to make energy and stay resilient? Vitamin M starts with a single question and works backward to the ingredients, forms, and doses.” "Every ingredient should have a job. Every job should support the same mission." "Every ingredient in Vitamin M was selected because the mitochondria actually need it — not because the label needed it." "Mitochondrial health isn't another wellness trend—it's the foundation beneath every wellness trend." - Key Points ⚡ Conventional multivitamins were created to prevent deficiency diseases such as scurvy, beriberi, pellagra, and rickets—not to optimize energy or longevity. ⚡ Recommended daily allowances represent minimum deficiency-prevention levels, not necessarily optimal amounts for cellular performance. ⚡ Many traditional multivitamins use inexpensive or inactive forms that the body must convert before they can be utilized. ⚡ Common examples include folic acid instead of bioactive folate, cyanocobalamin instead of active B12, and poorly absorbed mineral oxides. ⚡ Kitchen-sink formulas often contain dozens of ingredients at doses too small to produce meaningful biochemical effects. ⚡ Certain nutrients may also compete for absorption when packed together without an intentional design. ⚡ The central problem with most multivitamins is that they lack a biological thesis or clearly defined system they are built to support. ⚡ Physical energy is fundamentally ATP, and approximately 90–95% of ATP is produced by the mitochondria. ⚡ Mitochondria also regulate hormones, calcium signaling, cellular cleanup, heat production, redox signaling, and programmed cell death. ⚡ Caffeine does not create energy; it temporarily blocks the brain’s perception of fatigue. ⚡ Vitamin M is stimulant-free and is designed to support the machinery that actually produces cellular energy. ⚡ The formula addresses four age-related mitochondrial challenges: declining NAD, inefficient electron transport, weakened mitochondrial quality control, and disrupted methylation. ⚡ Team 1 supports cellular energy currency with NMN and niacinamide to replenish and recycle NAD. ⚡ Team 2 supports ATP production with ubiquinol, active riboflavin, thiamine, pantothenic acid, and mitochondrial adenosylcobalamin. ⚡ Ubiq
• 
  The FDA’s Peptide Crossroads: Will Regulation Clean Up the Gray Market—or Drive It Deeper Underground? 13.07.2026 38Min.

  In this Deep Dive, Dr. Mike Belkowski examines the darker side of the rapidly growing peptide movement: unregulated sourcing, research-use-only products, online dosing communities, peptide stacking, questionable testing, and the widening gap between consumer experimentation and medical oversight. The episode begins with a recent review exploring how the success of GLP-1 drugs helped normalize self-injection and created an “Ozempic halo” around experimental peptides. Dr. Mike breaks down the digital peptide exposure pathway, the legal fiction of research-use-only labels, the risks of informal titration, and why a certificate of analysis may not confirm sterility, endotoxin safety, potency, or the quality of the vial actually being used. The second half turns to the FDA Pharmacy Compounding Advisory Committee’s July 23–24 review of BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon for possible inclusion on the Section 503A Bulks List. Dr. Mike explains what the proceeding does — and does not — mean, the FDA staff’s preliminary opposition, and three possible outcomes: favorable inclusion, rejection, or a substance-by-substance split decision. Ultimately, the central question is not whether peptide experimentation will continue. It is whether it will occur through accountable medical systems that improve testing and surveillance — or move further into an anonymous gray market operating beyond meaningful oversight. (Educational content only, not medical advice.) - Article Discussed in Episode: Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks - Key Quotes From Dr. Mike: “(Peptides) are relatively safe in the right hands — but can you really trust the sourcing and the quality?” “A certificate of analysis may be a veneer of professional legitimacy that lacks depth.” “A high purity percentage does not necessarily tell you about endotoxins, sterility, degradation, or the specific vial in your refrigerator.” “This (upcoming FDA approval hearing) not an FDA approval hearing for these peptides.” “What it could mean is that certain peptides gain a pathway into a more regulated, clinician-directed compounding environment.” “The committee must navigate the uncomfortable space between promising but incomplete science and the responsibility to protect patients.” “A restrictive decision may reduce access through licensed pharmacies without eliminating consumer demand.” “The organizations most likely to follow the rules could leave the market, while the organizations least concerned with the rules remain.” “The committee’s recommendations may determine whether the next chapter takes place inside the healthcare system—or even deeper inside the shadows.” - Key Points ⚡ The success of semaglutide, tirzepatide, and other injectable drugs has helped normalize self-injection and increased public interest in experimental peptides. ⚡ The “Ozempic halo” can cause consumers to assume that the word peptide automatically implies legitimacy, sophistication, and safety. ⚡ Approved peptide drugs and unapproved research peptides do not share the same level of clinical evidence, manufacturing oversight, or safety validation. ⚡ Research-use-only and “not for human consumption” labels often function as legal disclaimers while consumers use the products for self-administration. ⚡ Reddit, Discord, forums, and social media communities frequently provide reconstitution, dosing, stacking, and titration instructions outside clinical supervision. ⚡ Stacking several active peptides makes it difficult to determine which compound caused a benefit, side effect, laboratory change, or delayed complication. ⚡ Subjective dose adjustments based on appetite, sleep, recovery, or appearance create an informal and poorly monitored experimentation system. ⚡ A certificate of analysis may confirm identity or purity in a tested sample without establishing sterility, endotoxin burden, stability, pote
• 
  Peptides 101: The Molecular Language That Connects Mitochondria, Aging & the Future of Medicine 09.07.2026 39Min.

  In this Peptides 101 episode of The Energy Code, Dr. Mike Belkowski explains why peptides belong in a mitochondria-centered conversation. Rather than treating peptides as a separate wellness trend, he frames them as one of the body’s primary communication systems — molecular messages that instruct cells, influence mitochondrial function, regulate repair, modulate inflammation, and help coordinate energy production, adaptation, and longevity. Dr. Mike walks through the basics of peptide structure, origin, function, receptor activity, and biological location, showing how peptides can be classified as natural or synthetic, linear or cyclic, hormonal or regulatory, GPCR-targeting or intracellular, and much more. The episode also explains why mitochondrial-derived peptides like MOTS-c, Humanin, and SHLPs are especially important for the future of mitochondrial medicine. Ultimately, this episode presents peptides as the molecular language of life itself: tiny chains of amino acids that may help medicine shift from overriding biology to collaborating with it. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Individual amino acids are like letters. Peptides are words. Proteins are complete sentences or even entire chapters.” “Peptides are the molecular language of life itself.” “You cannot fully understand peptides without understanding mitochondria, and you cannot fully optimize mitochondria without understanding peptides.” “Peptides influence every one of these (Six Pillars of Mitochondrial Wellness).” “Peptides don’t replace mitochondria, of course, but they instruct mitochondria.” “Aging itself, in one way, shape, or form, is really a communication problem.” “One of the most exciting aspects of peptide science is the possibility of restoring healthier cellular communication.” “Light and peptides are partners in cellular communication.” - Key Points ⚡ Peptides and mitochondria are not separate conversations; they are deeply connected through cellular communication, energy production, repair, and aging. ⚡ Mitochondria are environmental sensors that respond to hormones, nutrients, inflammation, stress, circadian signals, exercise, and gut-derived inputs. ⚡ Peptides are one of the primary languages through which cells communicate with mitochondria. ⚡ Peptides can influence all six pillars of mitochondrial wellness: ATP production, mitogenesis, mitophagy, dynamics, redox balance, and light-driven signaling. ⚡ Hormonal peptides such as insulin, GLP-1, GIP, and glucagon regulate nutrient entry into cells and influence oxidative phosphorylation. ⚡ Mitochondrial-derived peptides such as MOTS-c can support metabolic flexibility, insulin sensitivity, and cellular stress adaptation. ⚡ Some peptide pathways help activate PGC-1α, the master regulator of mitochondrial biogenesis. ⚡ Peptide signaling can support mitophagy by helping cells recycle damaged mitochondria before they become dysfunctional. ⚡ Peptides can indirectly regulate mitochondrial fusion and fission through cellular stress-response networks. ⚡ Glutathione is technically a peptide and plays a major role in redox balance and antioxidant defense. ⚡ Red and near-infrared light can influence peptide production, growth factors, inflammatory mediators, and cellular repair pathways. ⚡ Aging can be viewed not only as accumulated damage, but also as a breakdown in cellular communication. ⚡ Mitochondrial-derived peptides show that mitochondria do not merely receive peptide signals — they also produce their own. ⚡ Humanin, MOTS-c, and SHLPs are mitochondrial-derived peptides that influence metabolism, inflammation, insulin sensitivity, stress resistance, and longevity. ⚡ Peptides are short chains of amino acids linked together by peptide bonds. ⚡ Amino acids are like letters, peptides are like words, and proteins are like sentences or chapters. ⚡ Natural peptides are produced by the body and are often short-lived because the body rapidly breaks them d
• 
  The Peptide Revolution: How These Molecular Messengers Could Rewrite Aging, Metabolism & Medicine 06.07.2026 23Min.

  In this Deep Dive, Dr. Mike Belkowski explores the rapidly expanding world of therapeutic peptides and why these highly specific signaling molecules may represent one of the most important frontiers in modern medicine. Drawing from a 2026 review in the International Journal of Molecular Sciences, the episode explains how peptides function as the body’s “biological software,” delivering precise molecular instructions that influence metabolism, tissue repair, inflammation, collagen production, cognitive function, mitochondrial health, and cellular resilience. Dr. Mike breaks down major peptide categories, including GLP-1 agonists such as semaglutide, tirzepatide, and retatrutide; regenerative peptides such as BPC-157 and TB-500; growth hormone secretagogues; GHK-Cu; Semax, Selank, and DSIP; mitochondrial peptides such as MOTS-c, Humanin, SHLP-2, and SS-31; and topical aesthetic peptides including Argireline and Matrixyl 3000. The episode also addresses the critical distinction between FDA-approved therapies and investigational compounds, emphasizing that peptide enthusiasm must be balanced with clinical evidence, product quality, regulatory awareness, and appropriate medical supervision. The emerging vision is not simply better drugs, but a future of personalized biological programming that works with the body’s own molecular language. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives - Key Quotes From Dr. Mike: “Each peptide binds to highly specific receptors like a key fitting into a lock.” “Peptide medicine represents a shift toward restoring biological communication before irreversible dysfunction occurs." "Unlike traditional stimulants or sedatives, (Semax & Selank) aim to optimize normal brain function without producing significant sedation or overstimulation.” “One of the newest frontiers in peptide science targets the very engines that power every cell — the mitochondria.” “Enthusiasm should always be balanced with scientific rigor, product quality, and appropriate medical supervision.” “The real revolution isn’t simply that we can create new peptides. It’s that we’re beginning to understand and speak the molecular language that has guided human biology for millions of years.” - Key Points Key Points ⚡ Peptides are short chains of amino acids that primarily function as highly specific biological signaling molecules. ⚡ Peptides can be thought of as the body’s “biological software,” delivering instructions that regulate repair, metabolism, inflammation, collagen production, mitochondrial function, and cellular survival. ⚡ Unlike many conventional drugs, therapeutic peptides often mimic or amplify signaling pathways that already exist naturally within the body. ⚡ Peptide medicine represents a shift from suppressing symptoms toward restoring healthier biological communication. ⚡ GLP-1 receptor agonists such as Semaglutide transformed obesity treatment by improving satiety, glucose regulation, insulin sensitivity, and caloric control. ⚡ Tirzepatide activates both GLP-1 and GIP receptors, while Retatrutide adds glucagon-receptor activation as a triple agonist. ⚡ Early Retatrutide trials produced average weight reductions exceeding 22% after approximately one year. ⚡ Metabolic peptides may eventually influence cardiovascular disease, fatty liver disease, kidney health, inflammation, and neurodegenerative processes — not merely weight loss. ⚡ Regenerative peptides such as BPC-157 and TB-500 are being investigated for tissue repair, angiogenesis, wound healing, muscle recovery, and inflammation modulation. ⚡ Growth hormone secretagogues such as Tesamorelin, Ipamorelin, and CJC-1295 stimulate the body’s own pulsatile growth hormone release. ⚡ GHK-Cu may influence thousands of genes related to collagen production, wound repair, antioxidant defense, infla
• 
  BioShilajit: Stop Borrowing Energy From Tomorrow (The 3-Part Mitochondrial Stack) [#1 Episode from First Half of '26] 02.07.2026 1Std. 15Min.

  Dr. Mike unveils BioShilajit — a “trio stack” built for mitochondrial performance: shilajit for ionic minerals + fulvic/humic support, PQQ to signal mitochondrial biogenesis (PGC-1α), and pharmaceutical-grade methylene blue as a low-dose electron-cycling “failsafe” for the respiratory chain. Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.” “Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.” “Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.” “Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.” “A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.” “PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.” “Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).” - Key Points Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December). Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs. BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system. Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption. ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described). Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy). PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling. Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy. Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities). - Episode timeline 00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus)00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role,
• 
  Your Mitochondria Have Their Own Clock — and It May Control How Fast You Age 29.06.2026 20Min.

  In this Deep Dive, Dr. Mike Belkowski explores a fascinating question at the intersection of circadian biology and mitochondrial science: What if mitochondria do not merely respond to the body’s clock, but actively help keep it? Drawing from two reviews on mitochondrial chronobiology, the episode examines how mitochondrial fusion, fission, energy production, mitophagy, NAD metabolism, and oxidative stress follow rhythmic patterns throughout the day. It also breaks down the two-way conversation between the nuclear clock and the mitochondria, including how metabolic signals such as NAD, ATP, AMP, and acetyl-CoA can reshape clock-gene activity. The discussion moves even deeper into evidence that biological rhythms can persist without a nucleus, suggesting that mitochondria may retain elements of an ancient metabolic clock inherited from their bacterial ancestors. Ultimately, the episode reveals why light, food timing, exercise, sleep, and metabolism must remain synchronized to preserve mitochondrial efficiency, metabolic health, resilience, and longevity. (Educational content only, not medical advice.) - Articles Discussed in Episode: The Circadian nature of Mitochondrial Biology  Circadian coordination: understanding interplay between circadian clock and mitochondria  - Key Quotes From Dr. Mike: “What if mitochondria aren’t just responding to the circadian clock? What if they’re helping actually keep it?” “Your circadian clock isn’t simply measuring time. It’s also measuring energy.” “Our mitochondria aren’t just passive recipients of that information. They’re active participants in deciding what time it actually is.” “When the nucleus and mitochondria are in sync, energy production peaks exactly when you need it.” “The mitochondria beat more to a metabolic clock... Consistent eating patterns provide the metabolic cues necessary to keep mitochondrial activity on beat.” “Mitochondria are rhythmic shape-shifters... Failing to maintain this shape-shifting rhythm (i.e. fusion & fission) is a hallmark of cellular aging and metabolic decline.” - Key Points ⚡ Mitochondria are not simply ATP-producing organelles; they are signaling hubs, redox regulators, environmental sensors, and cellular decision-makers. ⚡ The relationship between the circadian clock and mitochondria is a two-way conversation rather than a one-directional command from the nucleus. ⚡ Clock genes influence mitochondrial biogenesis, mitophagy, fusion, fission, oxidative phosphorylation, NAD metabolism, and reactive oxygen species production. ⚡ Mitochondria communicate back to the nucleus through metabolites such as NAD, ATP, AMP, acetyl-CoA, and cellular redox status. ⚡ The circadian clock may be measuring both time and energy. ⚡ Mitochondrial fusion and fission follow rhythmic patterns that help cells adapt their physical structure to changing energy demands. ⚡ Fusion creates elongated mitochondrial networks optimized for efficient oxidative phosphorylation and energy production. ⚡ Fission separates mitochondrial networks into smaller units, supporting quality control and the removal of damaged components. ⚡ Loss of the normal fusion-fission rhythm is associated with cellular aging, oxidative stress, and metabolic decline. ⚡ SIRT1 acts as a metabolic sensor linking NAD availability to clock proteins such as PER2. ⚡ Biological rhythms can exist without nuclear DNA, as demonstrated by circadian peroxiredoxin oxidation in enucleated red blood cells. ⚡ Mitochondria also exhibit approximately 12-hour ultradian rhythms that appear to respond more strongly to metabolic and cellular stress cues than to light. ⚡ These independent rhythms support the theory that mitochondria retained ancient biological clocks from their bacterial ancestors. ⚡ Disrupting clock genes such as BMAL1, PER1, or PER2 physically damages mitochondrial structure and impairs cellular respiration. ⚡ Peripheral clocks in organs such as the liver, heart, and skeletal muscle respond strongly to
• 
  Reset Your Circadian Rhythm: Morning Light, Dark Nights & the BioLight Ember 25.06.2026 43Min.

  In this episode of The Energy Code, Dr. Mike Belkowski explores why circadian rhythm is not merely a sleep issue — it is a foundational regulator of metabolism, hormones, cardiovascular health, inflammation, cognition, mitochondrial function, and longevity. Drawing from five influential research papers, Dr. Mike explains how the eyes act as circadian sensors, why the timing, spectrum, and intensity of light all matter, and how modern life creates a damaging mismatch: too little bright, full-spectrum light during the day and too much blue-rich artificial light at night. He also breaks down why morning sunlight may be one of the most powerful free wellness interventions available — and why nighttime success begins shortly after waking. The episode concludes with practical strategies for designing a more circadian-friendly environment and introduces the BioLight Ember, a portable, rechargeable light with adjustable brightness and three evening-friendly modes: amber, red, and amber/red combined. The central message is simple: you cannot out-supplement or out-biohack a poor circadian rhythm, but you can begin correcting it by sending your biology the right light signals at the right time. (Educational content only, not medical advice.) - Articles Discussed in Episode: Effects of light on human circadian rhythms, sleep and mood Circadian Rhythm, Lifestyle and Health: A Narrative Review Systematic review of light exposure impact on human circadian rhythm Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association The role of sunlight in sleep regulation: analysis of morning, evening and late exposure - Key Quotes From Dr. Mike: “You can’t out-supplement or out-biohack a poor circadian rhythm.” “The body doesn’t know what time it is. It only knows what signals it receives... Light is the strongest timing signal humans possess. Everything else is secondary.” “If there was one circadian intervention that consistently outperforms nearly every supplement, it’s morning sunlight.” “The goal isn’t to eliminate light altogether (at night). The goal is to become intentional about which light we’re exposing ourselves to and at what time.” “Health isn’t always about adding another piece of technology or nutraceutical. Sometimes it’s simply about changing the environment your biology evolved to expect.” - Key Points ⚡ Circadian rhythm is not simply about sleep; it influences metabolism, hormones, cardiovascular function, inflammation, cognition, mitochondrial health, and longevity. ⚡ Morning sunlight is one of the most powerful free habits for setting the body’s master clock and improving both daytime alertness and nighttime sleep. ⚡ The eyes contain specialized circadian sensors called intrinsically photosensitive retinal ganglion cells, or ipRGCs, that help determine whether the body interprets its environment as day or night. ⚡ The same light can produce opposite effects depending on when it is viewed. ⚡ Morning light advances the circadian clock, increases alertness, supports a healthy cortisol rise, and promotes earlier melatonin onset that evening. ⚡ Bright and blue-rich light at night delays the circadian clock, suppresses melatonin, increases alertness, and reduces sleep quality. ⚡ The body does not know what clock time it is — it responds to environmental signals, with light acting as the strongest timing cue. ⚡ Virtually every major organ and tissue contains its own molecular clock, including the liver, pancreas, gut, immune system, and mitochondria. ⚡ Shift work, late-night eating, artificial lighting, social jet lag, inconsistent schedules, and sleep deprivation all contribute to circadian mismatch. ⚡ Modern indoor lighting is often too dim during the day and too bright at night. ⚡ Typical indoor environments provide roughly 100–500 lux, while outdoor daylight can reach approximately 10,000–100,000 lux. ⚡ Circadian responses depend on both the brightness a
• 
  CrossFit Athlete Recovery Tool Battle: Compression Boots vs. Red Light Therapy 24.06.2026 13Min.

  In this Deep Dive, Dr. Mike breaks down a randomized crossover trial comparing photobiomodulation, pneumatic compression boots, shockwave therapy, and passive rest in CrossFit athletes. The findings reveal a striking disconnect between feeling recovered and actually being physiologically recovered. Compression boots and shockwave therapy earned high satisfaction scores, but failed to outperform passive rest for muscle damage or power recovery. Photobiomodulation combined with a static magnetic field was the only intervention to preserve vertical-jump performance, reduce biochemical markers of muscle damage, and strengthen endogenous antioxidant defenses over the following 24 to 48 hours. The episode explores the study’s specific light protocol, the “invisible recovery window” immediately after intense exercise, and why mitochondrial and oxidative-stress recovery may matter more than how your legs feel in the moment. (Educational content only, not medical advice.) - Article Discussed in Episode: A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes - Key Quotes From Dr. Mike: “The most striking finding was the massive disconnect between an athlete’s subjective feelings and their objective physiology.” “Shock waves and compression boots might make post-WOD soreness more bearable, but they simply don’t help you regain peak power any faster.” “Photobiomodulation combined with a static magnetic field was the only intervention that significantly outperformed passive rest.” “To understand why photobiomodulation won, you have to look at the microscopic war zone inside your muscle cells... High-intensity CrossFit workouts trigger a massive spike in reactive oxygen species... Photobiomodulation acts as an internal antioxidant booster.” “Pneumatic boots are mostly for show... The boots provided no statistically significant benefit over passive recovery for muscle damage or power output.” “If you want to return to the barbell with maximum power, photobiomodulation is currently the only technology in this trial with scientific receipts to back it up.” - Key Points ⚡ The study compared photobiomodulation with a static magnetic field, pneumatic compression boots, shockwave therapy, and passive recovery in CrossFit athletes. ⚡ Compression boots and shockwave therapy received 83% satisfaction ratings, showing that athletes enjoyed the treatments. ⚡ Despite those high satisfaction scores, neither treatment significantly improved vertical-jump recovery or muscle-damage markers compared with passive rest. ⚡ The study highlights a major disconnect between subjective recovery and objective physiological recovery. ⚡ Photobiomodulation combined with a static magnetic field was the only intervention to significantly outperform passive recovery across functional and biochemical outcomes. ⚡ Athletes receiving PBM retained more vertical-jump power at the 24- and 48-hour marks. ⚡ PBM also reduced lactate dehydrogenase, a biomarker associated with muscle-cell membrane damage. ⚡ The study used a 32-minute protocol across eight treatment sites on each lower limb, targeting the quadriceps, hamstrings, and calves. ⚡ The device combined 905-nanometer super-pulsed lasers with 850-nanometer and 633-nanometer LEDs. ⚡ None of the recovery methods restored jump performance at the one-hour mark, including PBM. ⚡ PBM nevertheless increased antioxidant activity within 60 minutes, suggesting internal repair had begun before athletes felt or performed better. ⚡ PBM lowered markers of lipid and protein oxidation, including TBARS and carbonylated proteins. ⚡ It was also the only intervention to maintain or increase superoxide dismutase and catalase activity. ⚡ Compression boots may provide a strong sensory experience, but this trial did not show meaningful metabolic or performance recovery. ⚡ The central lesson: choose recovery tools based on how they affect performance 24 to 48 hours later—not mer
• 
  Can Red Light Protect Your Eyes and Improve Sleep? The New Frontier of Photobiomodulation 22.06.2026 30Min.

  In this Deep Dive, Dr. Mike Belkowski returns to the roots of The Energy Code by examining two newly published reviews on red light therapy. The first explores photobiomodulation for ocular aging and eye diseases, including age-related macular degeneration, dry eye, and childhood myopia. The second evaluates whether PBM can improve sleep quality by influencing brain metabolism, cerebral blood flow, neural networks, and melatonin-related pathways. Dr. Mike breaks down how light interacts with mitochondrial cytochrome c oxidase, improves electron flow and ATP production, and may restore bioenergetics in two of the body’s most energy-demanding tissues: the brain and retina. The episode also examines the LIGHTSITE clinical trials, repeated low-level red-light therapy for myopia, transcranial PBM for sleep, extra-pineal melatonin production, and why proper wavelength, irradiance, and dosage remain essential. The emerging message is that red light may be far more than a tool for skin, pain, and muscle recovery. It may represent an investigational strategy for restoring cellular energy in the tissues responsible for how clearly we see and how deeply we sleep. (Educational content only, not medical advice.) - Article Discussed in Episode: Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review Photobiomodulation and sleep quality: systematic review and meta-analysis - Key Quotes From Dr. Mike: “Many of the conditions we associate with aging and declining function may ultimately be manifestations of an underlying energy problem.” “We are witnessing a bioenergetic tipping point where mitochondrial decay dictates the pace of systemic aging.” “The human eye is an ideal target for PBM due to its optical accessibility and the immense energy demands of the retina.” “Brief exposures to red light can slow the progression of myopia in children.” “PBM may help restore homeostatic sleep pressure — the biological need to sleep... Red and near-infrared wavelengths have the capability of improving our systemic melatonin production.” “The gastrointestinal tract is likely the largest source of melatonin in the body.” “If mitochondria contribute to melatonin production, all of a sudden full-body red light therapy becomes imperative for normalizing circadian rhythm.” - Key Points ⚡ Two new reviews examine photobiomodulation for ocular aging and disease and for sleep quality. ⚡ The brain and retina are among the body’s most energy-demanding tissues, making them especially vulnerable to mitochondrial decline. ⚡ Red and near-infrared light interact with cytochrome c oxidase, helping displace inhibitory nitric oxide, restore oxygen utilization, and increase ATP production. ⚡ PBM follows a Goldilocks dose response: too little may do nothing, while excessive light can become inhibitory or pro-oxidative. ⚡ The LIGHTSITE clinical trials reported modest but statistically significant visual-acuity gains of roughly four to five ETDRS letters in patients with dry age-related macular degeneration. ⚡ Ocular PBM may also reduce drusen burden and potentially slow geographic atrophy, although further clinical confirmation is needed. ⚡ Repeated low-level red-light therapy is being studied as a way to slow the abnormal eyeball elongation responsible for childhood myopia. ⚡ Ocular protocols differ by goal: age-related macular degeneration often uses multiple red, amber, and near-infrared wavelengths, while myopia protocols typically use red light alone. ⚡ Wavelength determines penetration depth; device strength primarily determines how quickly a therapeutic dose is delivered. ⚡ High-powered panels should not be used close to the eyes without carefully adjusting distance, exposure time, and irradiance. ⚡ Transcranial PBM may support sleep by influencing adenosine signaling, cerebral metabolism, astrocytes, and prefrontal and thalamocortical networks. ⚡ Current sleep findings are statistically promising, but may not yet re
• 
  The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 3 18.06.2026 1Std. 10Min.

  In Part 3 of his presentation at Dave Asprey's BEYOND Biohacking conference in May, Dr. Mike completes this three-part series by moving fully into the practical applications of mitochondrial optimization. After recapping the six pillars of mitochondrial function — energy production, mitogenesis, mitophagy, dynamics, ROS protection, and light — this episode breaks down the major tools, compounds, and lifestyle strategies that can help support each pillar. Dr. Mike covers urolithin A and B, shilajit, mitochondrial peptides, nano gold, taurine, molecular hydrogen, deuterium depletion, hyperbaric oxygen therapy, circadian light, indoor lighting, and grounding. The episode then brings everything together into a practical “Energy Code Blueprint,” outlining a daily and weekly framework for the true mitochondriac: sunlight, grounding, mitohormesis, red light therapy, methylene blue, selective antioxidants, mitochondrial peptides, and foundational compounds that support cellular energy, resilience, and longevity. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “Urolithin A is simply one of the most effective, efficient, efficacious ways to activate the mitophagy switch.” “SS-31 arguably is the top peptide I would recommend for overall mitochondrial function.” “MOTS-c… is essentially exercise in a molecule... Humanin… is known as a cognitive or neuroprotector in terms of a peptide... SHLP-2… is the cellular survival signal peptide... (SS-31, MOTS-c, Humanin & SHLP-2) are the peptides I would look at from a mitochondriac perspective.” “Nano gold itself doesn’t create energy; it multiplies & amplifies the light that does.” “Molecular hydrogen penetrates every cellular compartment, including the mitochondria.” “Deuterium depletion is one of the most powerful overlooked levers to upgrade mitochondrial function.” “Morning sun is a must.” - Key Points ⚡ This episode completes the three-part breakdown of The Energy Code Blueprint: Longevity Starts in the Mitochondria. ⚡ Part 3 focuses on the practical applications: what people can actually do to support the six pillars of mitochondrial function. ⚡ Urolithin A is framed as one of the most effective ways to activate mitophagy, helping clear damaged mitochondria and restore mitochondrial quality control. ⚡ Urolithin B is positioned as an anabolic mitokine that may support muscle retention, protein synthesis, joint health, and metabolic resilience. ⚡ Shilajit is described as a foundational mitochondrial compound because of its fulvic acid, trace minerals, CoQ10 support, and ability to improve ATP and EZ water production. ⚡ The four core mitochondrial peptides highlighted are SS-31, MOTS-c, SHLP-2, and Humanin, with honorable mentions for Epitalon, GHK-Cu, and Pinealon. ⚡ Nano gold is presented as a light-amplifying mitochondrial tool that may enhance the effects of red and near-infrared light via surface plasmon resonance. ⚡ Taurine is described as a mitochondrial game changer due to its effects on oxidative stress, ETC efficiency, mitophagy, inflammation, brain health, heart health, and calcium regulation. ⚡ Molecular hydrogen is framed as a selective antioxidant that neutralizes the most harmful radicals while preserving beneficial redox signaling. ⚡ Deuterium depletion is explained as an overlooked lever for improving ATP synthase efficiency, electron flow, mitochondrial respiration, and cellular energy. ⚡ Hyperbaric oxygen therapy is discussed as a mitochondrial oxygenation strategy that may improve ATP production, mitogenesis, cellular repair, and the nitric oxide “golden ratio.” ⚡ Circadian light hygiene—morning sun, evening darkness, amber/red lighting, and blue-light blocking—is positioned as a foundational mitochondrial signal. ⚡ Grounding is described as a free electron-transfer strategy that supports redox potential, inflammation control, blood flow, sleep, and mitochondrial function. ⚡ The final Energy Code Blueprint begins with the free
• 
  Humanin: The Longevity Peptide Hidden Inside Your Mitochondria 16.06.2026 17Min.

  In this peptide-focused Deep Dive, Dr. Mike explores Humanin, one of the most fascinating and underappreciated mitochondrial-derived peptides in the longevity space. First discovered in 2001 while researchers were searching for molecules that could protect neurons from Alzheimer’s-related toxicity, Humanin appears to act as one of the body’s natural cellular survival signals — helping cells withstand oxidative stress, inflammation, mitochondrial damage, metabolic dysfunction, and age-related decline. This episode breaks down a 2023 systematic review from Biology titled “Humanin and Its Pathophysiological Roles in Aging”, covering Humanin’s unusual mitochondrial origin, its role in neuroprotection, mitohormesis, chaperone-mediated autophagy, metabolic health, cardiovascular function, inflammation, and lifespan research. Dr. Mike also explains why Humanin may deserve a place alongside SS-31 and MOTS-c as one of the top mitochondrial peptides for anyone interested in mitochondrial wellness, resilience, and longevity. (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and Its Pathophysiological Roles in Aging: A Systematic Review - Key Quotes From Dr. Mike: “Humanin was originally isolated from surviving neurons in the brains of patients with Alzheimer’s disease" "It was named 'Humanin' to reflect its potential role in preserving human health and survival."  “Humanin appears to function as one of the body’s natural cellular survival signals... acting as a molecular shield and mitokine." “Humanin restores the communication link that tells the cleanup crew exactly where the toxic debris is hiding.” “By addressing the mitochondrial origin of this inflammation — the leaky battery problem — Humanin hits multiple diseases simultaneously.” "These are the top three peptides if you’re a mitochondriac: SS-31, MOTS-c, and now you can see why the third is Humanin.” - Key Points ⚡ Humanin is a small mitochondrial-derived peptide first discovered in 2001 during research into Alzheimer’s disease-related neuronal protection. ⚡ It was originally isolated from surviving neurons in the brains of Alzheimer’s patients, which helped shape its identity as a cellular survival peptide. ⚡ Humanin is encoded within the mitochondrial genome, specifically inside the 16S ribosomal RNA gene, giving mitochondria their own “voice” beyond ATP production. ⚡ It exists in two forms: a 21-amino-acid version when translated in mitochondria and a 24-amino-acid version when translated in the cytoplasm. ⚡ Humanin is highly conserved across species, suggesting it may play a fundamental role in multicellular survival and stress resistance. ⚡ It may protect against Alzheimer’s-related toxicity by interfering with amyloid beta toxicity and blocking pro-apoptotic pathways like Bax activation. ⚡ Humanin functions as a mitokine, released during periods of mitochondrial stress to coordinate resilience across cells and tissues. ⚡ Humanin levels generally decline with age, although some very old individuals may show compensatory spikes as a last-ditch mitohormetic stress response. ⚡ It supports chaperone-mediated autophagy, helping the cell’s “precision cleanup crew” remove damaged or oxidized proteins. ⚡ Humanin has broad systemic effects, including potential benefits for brain health, cardiovascular aging, insulin sensitivity, visceral fat, lean mass, inflammation, stem cell survival, and reproductive health. ⚡ Animal models suggest even modest increases in circulating Humanin may provide protection against toxic insults and inflammatory markers. ⚡ A synthetic analog called HNG / Humanin S14G may be up to 1,000 times more potent than naturally occurring Humanin in certain models. ⚡ Dr. Mike frames Humanin as the third part of a mitochondrial peptide “big three” alongside SS-31 and MOTS-c. - Episode timeline 0:00–0:40 — Introduction to Humanin as another mitochondrial-derived peptide; article title and source0:40–1:47 — Historical o
• 
  BPC-157: A “Miracle” Healing Peptide or Gray-Market Hype? 15.06.2026 19Min.

  In this episode of The Energy Code, Dr. Mike Belkowski breaks down BPC-157, one of the most popular and debated peptides in the wellness, recovery, and biohacking worlds. He covers its origins as a synthetic fragment of a protective compound found in gastric juice, its potential roles in tendon, ligament, muscle, gut, nerve, and tissue repair, and the major caveat around angiogenesis. The episode then unpacks a recent Pharmaceutics review highlighting the central paradox of BPC-157: decades of compelling animal data and powerful anecdotal reports, but still a major lack of rigorous human clinical evidence, standardized formulations, and long-term safety data. Ultimately, BPC-157 is framed as a high-potential, low-certainty peptide — promising enough to deserve serious attention, but not yet proven enough to justify blind faith. (Educational content only, not medical advice.) - Article Discussed in Episode: BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers - Key Quotes From Dr. Mike: “BPC-157 has been investigated primarily through studies looking at gastrointestinal protection, tissue repair, and healing mechanisms.” “BPC-157’s gastric stability does not equal oral bioavailability… “The claim that oral BPC-157 reaches systemic circulation is an unverified hypothesis, not a clinical fact.” “It enters the blood, triggers a response, and is cleared by the kidneys almost instantly. Yet its healing effects can persist for days or weeks.” “There are over 544 peer-reviewed studies, mostly in rodents… In terms of total human efficacy subjects, there’s fewer than 30 people documented in all history.” “For now, BPC-157 remains the ultimate biological paradox: a compound that can seemingly heal anything in the lab, but officially nothing in the clinic.” - Key Points ⚡ BPC-157 stands for Body Protecting Compound 157 and is derived from a protective protein found in human gastric juice. ⚡ It has been studied mostly in animal models for tissue repair, tendon healing, ligament recovery, muscle injury, gut protection, angiogenesis, nerve support, inflammation modulation, and oxidative stress reduction. ⚡ Despite its popularity, BPC-157 has almost no robust human clinical data. ⚡ A recent Pharmaceutics review describes BPC-157 as an investigational peptide with major formulation, pharmacokinetic, regulatory, and translational barriers. ⚡ BPC-157 is unusually stable in acidic stomach-like environments, but gastric stability does not prove oral bioavailability. ⚡ Its systemic half-life appears to be under 30 minutes, yet animal studies suggest effects may last days or weeks, creating a major pharmacokinetic/pharmacodynamic mystery. ⚡ The review suggests BPC-157 may act as a transcriptional primer, briefly triggering gene and growth-factor cascades that continue after the peptide is cleared. ⚡ The evidence base is heavily skewed toward preclinical animal studies, with very limited human data. ⚡ Much of the BPC-157 literature comes from one research group at the University of Zagreb, creating a need for independent replication. ⚡ BPC-157’s native stability may make it difficult to patent, reducing pharmaceutical incentive to fund large clinical trials. ⚡ Current gray-market products are research chemicals, not FDA-approved pharmaceutical-grade human therapeutics. ⚡ Potential risks include inconsistent dosing, lack of GMP oversight, lack of long-term safety data, and theoretical concern around angiogenesis in the setting of hidden malignancy. ⚡ Dr. Mike’s view: BPC-157 has earned scientific curiosity, but not scientific certainty. - Episode timeline 0:00 – Introduction to BPC-157Dr. Mike introduces BPC-157 as one of the most popular peptides outside the GLP-1 category and explains that BPC stands for Body Protecting Compound 157.   0:49 – The Review Being CoveredThe episode centers on a recent Pharmaceutics review titled BPC 157 as an Investiga
• 
  The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 2 11.06.2026 57Min.

  In Part 2 of Dr. Mike's podcast special of his presentation from Dave Asprey's BEYOND Biohacking Conference, we finish all six pillars of mitochondrial wellness — from mitophagy (quality control) & mitochondrial dynamics (fusion/fission balance) to ROS intelligence (selective antioxidant strategy) & light (red/NIR as the master signal). Then we move from theory to action: the episode begins the “applications” section with a practical, research-backed toolkit — red light therapy, methylene blue, blue spirulina, & Carbon 60 — including how they work, how they stack, & why the right strategy is less about “more antioxidants” & more about restoring electron flow, managing oxidative stress, & building cellular resilience. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “If mitophagy is not working properly, then those damaged mitochondria are allowed to linger and be pro-inflammatory and be pro-oxidative stress.” “Specifically, red and near-infrared are the spectra that excites the mitochondria and the cytochrome c oxidase. No other wavelengths accomplish this.” “Simply by exposing your body… to red and near-infrared light (whether sun or red light therapy devices)… this is likely the most powerful way to remedy mitochondrial dysfunction.” “Methylene blue is one of the only ways I know of that’s able to actually restore energy in mitochondria with broken electron transport chains.” “We have an amazing natural alternative to methylene blue… and that is blue spirulina, which has phycocyanins that absorbs red light to protect neurons and strengthen our mitochondrial performance.” “Carbon 60 is essentially a free radical sponge… it’s only gonna remove the excess ‘bad’ free radicals and allow the good signaling molecules to stay.” - Key Points ⚡️ Mitophagy = mitochondrial quality control: PINK1 “inspects,” Parkin “tags,” autophagosomes “remove.” When it fails, damaged mitochondria linger & inflammation/oxidative stress snowball. ⚡️ Dysfunctional mitochondria can self-propagate, accelerating decline unless quality control is restored. ⚡️ Mitochondrial dynamics (fusion/fission) is a Goldilocks game: Too much fission → fragmentation & energy collapse Too much fusion → damage spreading through hyperfusion ⚡️ ROS aren’t “all bad”: low-level ROS are essential signals; the goal is selective antioxidant defense, not blanket quenching. ⚡️ Light is a mitochondrial master regulator: red/NIR stimulate cytochrome c oxidase, dissociate nitric oxide, allow oxygen back in → better ATP + EZ water. ⚡️ Red light therapy is wavelength-driven, not “power-driven”: red = skin; NIR = deeper tissues; power mainly affects time-to-dose. ⚡️ Methylene blue = electron chaperone: bypasses ETC bottlenecks (esp. complex I/III) by shuttling electrons toward complex IV; synergizes with red light. ⚡️ Blue spirulina (phycocyanin) = natural photodynamic partner: less potent than MB but strong synergy with red light; quality matters (E10→E40). ⚡️ Carbon 60 = selective free radical sponge: mops up “excess” ROS while preserving beneficial signaling; quality control is crucial. - Episode timeline 0:00–2:00 — Why this “Part 2” exists (no event time limit) + recap: bioenergetics + pillars 1–2 from Part 1 2:00–8:30 — Pillar 3: Mitophagy (PINK1/Parkin, why failure drives disease, self-propagation, urolithin A mention) 8:30–12:45 — Pillar 4: Mitochondrial dynamics (fusion vs fission, benefits, dangers of imbalance) 12:45–16:30 — Pillar 5: ROS protection (signal vs damage, selective antioxidants, why “antioxidant overload” backfires) 16:30–25:00 — Pillar 6: Light (cytochrome c oxidase, NO vs oxygen competition, why red/NIR are special, darkness as a mitophagy signal) 25:00–33:00 — Applications begin: Red light therapy (wavelength vs penetration, power vs efficiency, dosing logic, third-party testing) 33:00–41:45 — Methylene blue (electron chaperone + regenerative redox cycling + brain affinity + SSRI nuance
• 
  MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience 08.06.2026 30Min.

  In this peptide-focused Deep Dive, Dr. Mike moves from SS-31 to MOTS-c — one of the most popular mitochondrial-derived peptides for metabolic resilience and mitochondrial wellness. You’ll get a fast, practical primer (what it is + key benefits), then a walkthrough of a review titled “MOTS-c Functionality Prevents Metabolic Disorders,” explaining how MOTS-c acts as a mitochondrial “telegram” to your DNA via retrograde signaling. The episode breaks down MOTS-c’s “exercise mimetic” mechanisms (AMPK activation via AICAR), its reported effects across metabolism, muscle, bone, immune aging, and senescence clearance, and finishes with an actionable playbook for supporting endogenous MOTS-c through mitohormetic lifestyle inputs — and a thoughtful strategy for stacking MOTS-c with SS-31. (Educational content only, not medical advice.) - Article Discussed in Episode: MOTS-c Functionally Prevents Metabolic Disorders - Key Quotes From Dr. Mike: “MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.” “MOTS-c functionally prevents metabolic disorders.” “When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.” “Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…” “Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.” “If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.” - Key Points SS-31 and MOTS-c are framed as the “top two” mitochondrial peptides (SS-31 = not mitochondrially-derived but highly mito-targeted; MOTS-c = mito-derived). MOTS-c is positioned as a mitochondrial optimization + metabolic flexibility peptide and an “exercise mimetic.” Core benefits highlighted: energy production, glucose utilization/insulin sensitivity, body composition, endurance/recovery, stress adaptation, longevity support. Big concept: mitochondria aren’t passive; they signal back to the nucleus. MOTS-c can translocate to the nucleus under metabolic stress and regulate gene expression. Mechanism highlighted: MOTS-c disrupts folate–methionine cycle → increases AICAR → activates AMPK → boosts fatty acid oxidation + insulin sensitivity. Review claims include: prevention of diet-induced obesity; possible cardiac protection against remodeling (NRG1–ERBB4 pathway mentioned). Longevity genetics angle: a mitochondrial polymorphism (noted as prevalent in Japanese population) may alter MOTS-c structure and associate with exceptional lifespan. Frailty/bone/muscle: MOTS-c described as inhibiting FOXO1 (muscle wasting signals), supporting myotube formation (STAT3), and reducing osteoclast differentiation (anti-osteoporosis). “Endogenous edge”: as a bioidentical peptide, MOTS-c is framed as potentially less immunogenic than some drugs, but oral delivery is a challenge due to peptide fragility. Practical close: best endogenous stimuli are mitochondrial challenges—exercise, fasting, heat/cold, hypoxia—plus circadian alignment and mitochondrial support nutrients. - Episode timeline 0:00–1:55 — Transition from SS-31 to MOTS-c; why MOTS-c is a “top two” peptide; new format: quick primer before the paper 1:55–4:33 — MOTS-c snapshot: what it is + core benefits list (metabolism, insulin sensitivity, fat loss, endurance, longevity) 4:33–7:57 — Review intro: mitochondria as control centers; retrograde signaling; MOTS-c as a mitochondrial messenger to DNA 7:57–10:44 — “Exercise mimetic” mechanism: folate–methionine cycle → AICAR → AMPK; obesity/metabolic protection examples 10:44–12:05 — Longevity genetics: MOTS-c polymorphism + “nature vs nurture” discussion 12:05–13:52 — Frailty defense: muscle (FOXO1/STAT3), bone (osteoclast suppression; OPG/RANKL mention) 13:52–15:46 — Endogenous/bioidentical angle; immune aging + senescen
• 
  SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source 05.06.2026 14Min.

  This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.” “These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…” - Key Points SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline. Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity. SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding. The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace. SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms. Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose). Mechanistically, SS-31 is explained as: Cardiolipin binding → supports OXPHOS efficiency/ATP output ROS scavenging (tyrosine residue) → reduces oxidative damage SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge). A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability. Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later. - Episode timeline 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive 0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters 3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate 5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent) 6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance) 8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”) 9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS) 11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT)Gro
• 
  The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1 04.06.2026 1Std. 2Min.

  In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.” - Key Points ⚡️ Longevity is downstream of bioenergetics: more energy produced per cell → more vitality; less energy → disease trajectory. ⚡️ Mitochondria are upstream of symptoms: dysfunction can precede diagnosis by years/decades. ⚡️  “Healing is Voltage”: redox potential, electron availability, pH, and inflammation are tightly linked. ⚡️ Mitochondria are not just power plants — they are environmental sensors (MIPS) driving epigenetic gene expression via retrograde signaling. ⚡️ Mitohormesis reframes “stress” as a dose-dependent upgrade signal for mitochondria (exercise, fasting, cold/heat, light, key compounds). ⚡️ Cardiolipin is presented as “the mitochondria of the mitochondria,” central to cristae structure, ETC organization, and mitochondrial aging. ⚡️ SS-31 is framed as a top-tier cardiolipin-targeting peptide; MOTS-c, Humanin, SHLP-2 as key mitochondrial-derived peptides. ⚡️ Energy production includes ATP + EZ water: ATP as immediate currency; EZ water as mitochondrial “battery pack” and hydration reserve. ⚡️ Red and near-infrared light are positioned as major tools to expand EZ water and support mitochondria across multiple pillars. ⚡️ The presentation tees up a “6 pillars” framework and promises a next episode continuation (pillars 3–6 + applications). - Episode timeline 00:00–01:55 — Special edition + Beyond Biohacking context; BioLite Labs intro (peptides focus)   01:55–04:52 — Talk format notes + offer to email slides as a resource   04:52–08:54 — Overview: bioenergetics → 6 pillars → optimization strategies → “day in the life” blueprint   08:55–11:02 — Bioenergetics foundation: “more energy per cell = more vitality” (Doug Wallace framing)   11:03–13:50 — Mitochondria as root cause: cells → tissues → organs → systems; symptoms appear late   13:51–17:32 — Voltage/redox: electrons, pH, inflammation; examples (sunlight, grounding, electron-rich strategies)   17:33–19:04 — “Anti-aging via electrons”: shared thread across many wellness strategies   19:07–21:21 — Mi
• 
  Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse 03.06.2026 20Min.

  This Deep Dive breaks down a preprint review from Free Radical Biology & Medicine titled “Mitoredox Shifts in Mitochondrial Dysfunction.” Dr. Mike opens with a TL;DR and then goes deeper into the core idea: a “mitoredox shift” (a disruption in mitochondrial redox balance) may be the unifying axis linking oxidative stress to mitochondrial quality-control failure, genome instability, heteroplasmy drift, and regulated cell death. The episode draws a clean line between primary genetic mitochondrial syndromes and far more common secondary mitochondrial dysfunction driven by environmental/metabolic stressors, then explores five big concepts: why redox imbalance collapses mitophagy and mtDNA stability, how “healthy” mitochondria can become hyperactive and accelerate disease, the 60–80% heteroplasmy tipping point, the reperfusion paradox, and emerging frontiers like mitochondrial transplantation, AI-driven oculomics, and new redox-modulating drugs — plus Dr. Mike’s “mitochondrial triad” lens (red light, methylene blue, C60). (Educational content only, not medical advice.) - Article Discussed in Episode: Mitoredox shifts in mitochondrial dysfunction - Key Quotes From Dr. Mike: “Mito-redox shifts… serve as a central link between oxidative stress and various diseases.” “These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…” “We are entering an era of mito redox medicine where we manage the electron flow of life itself.” “The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.” “Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease." - Key Points The review frames mitoredox shifts as a central link between oxidative stress and diverse diseases. Distinguishes primary mitochondrial syndromes (genetic) vs secondary disorders (environmental/metabolic)—with secondary being far more common. Mitoredox shifts destabilize mitophagy + mtDNA stability, leading to dysfunctional organelle buildup and cell death. The shift acts like an upstream master switch, biasing cells toward regulated death programs (e.g., ferroptosis, cuproptosis). “Healthy mitochondria can be hyperactive”: compensatory overwork can spike ROS and accelerate heteroplasmic drift. Heteroplasmy threshold: symptoms often emerge when mutated mtDNA crosses ~60–80%. Proposed takeover mechanisms: faster replication of truncated genomes, mitophagy decline, “survival of the sickest” evasion, random drift. Reperfusion paradox: restoring oxygen after ischemia can trigger a ROS surge that worsens injury and inflammation. Diagnostics: biomarkers + retinal imaging/oculomics, with AI methods potentially detecting dysfunction yearsearly. Therapeutics: mitochondrial transplantation, novel redox modulators (e.g., PMX 500FI), and “electron-flow stabilization” strategies. - Episode timeline 0:00–0:20 — Intro + review title + journal + preprint context (publishing Sept 2026) 0:20–1:22 — New format: TL;DR first, then deeper dive 1:22–2:56 — TL;DR: mitoredox shifts as the bridge between oxidative stress and disease; primary vs secondary; diagnostics + therapies; goal = restore homeostasis 3:00–5:01 — Mythology + endosymbiosis framing: “bioenergetic fire,” mitochondria as life/death controllers 5:01–6:58 — Concept 1: Mitoredox shift as the “unified field theory” linking ROS/antioxidants, QC failure, genome instability, regulated cell death 7:03–9:05 — Concept 2: “Healthy mitochondria” hyperactivity + metabolic asymmetry + heteroplasmic drift 9:05–11:59 — Concept 3: 60–80% tipping point; takeover mechanisms; aerobic glycolysis as a “stealth” adaptation 11:59–13:38 — Concept 4: reperfusion paradox; ROS overload → vascular destabilization + inflammation; eye/oculomics rel
• 
  The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch 02.06.2026 14Min.

  Atrial fibrillation is typically treated like an electrical glitch — rate control, rhythm control, anticoagulation. But this Deep Dive explores a newer frame: AFib may be driven by metabolic collapse and fibrotic remodeling rooted in mitochondrial dysfunction. Dr. Mike breaks down a May 5 Biomedicines paper titled “Humanin and MOTS-c attenuate atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction,” highlighting why mitochondrial-derived peptides (MDPs) — Humanin and MOTS-c — may function as stress-responsive guardians that help preserve mitochondrial integrity, reduce oxidative stress, and blunt fibrosis. You’ll hear the key human tissue findings (both peptides downregulated in AFib atrial appendages), the biomarker signal (plasma MOTS-c inversely tracking NT-proBNP), the “Humanin paradox” (plasma up while atrial tissue down), and the mouse data showing peptide treatment reduced AFib inducibility and structural remodeling. The episode closes with a big question: if heart health is about fueling cellular engines, not just fixing wiring, how does that reshape aging medicine? (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction - Key Quotes From Dr. Mike: “For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.” “In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.” “Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.” “Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…” “These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.” - Key Points The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction. AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.” Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers. AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology). Severity link: more depletion → more structural damage/fibrosis. Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP. The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead. In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling. Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6. Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways. - Episode timeline 0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine” 0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem 2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology 3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling 4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP 6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway 7:56–9:47 — Mouse model: HNG + MOTS-